Company Profile

BioReliance Corporation (AKA: Microbiological Associates Inc)
Profile last edited on: 11/2/18      CAGE:       UEI: H3KAG9A26K77

Business Identifier: NO Business Identifier is currently available for this company.
Year Founded
1947
First Award
1985
Latest Award
2001
Program Status
Inactive (Acquired)
Popularity Index
Is this YOUR Company?
Ensure accuracy and completeness of YOUR Company Profile by completing the brief Survey Instrument attached
Do you know about this Awardees?
Let us encourage you to provide any data which would enhance the completeness of this firm's profile.

Location Information

14920 Broschart Road
Rockville, MD 20850
   (301) 738-1000
   info@bioreliance.com
   www.bioreliance.com
Location: Multiple
Congr. District: 08
County: Montgomery

Public Profile

In December 2003, Biorelaince was acquired by Invitrogen, itself formerly quite extensively SBIR involved. BioReliance Corporation had provided contract services organization in testing and development and manufacturing for biologics and other biomedical products to biotechnology and pharmaceutical companies worldwide. Through its testing and development business segment, the Company evaluated products to ensure that they were free of disease-causing agents or do not cause adverse effects, characterizes products' chemical structures, develops formulations for long-term stability and validates purification processes under regulatory guidelines. In it manufacturing business segment, BioReliance developed production processes and manufactured biologics on behalf of clients, both for use in clinical trials and for the worldwide commercial market.

Extent of SBIR involvement

User Avatar

Synopsis: Awardee Business Condition

Employee Range
20-24
Revenue Range
2M-2.5M
VC funded?
Yes
Public/Private
Publicly Traded
Stock Info
NASDAQ : BREL
IP Holdings
1-4

Awards Distribution by Agency

Most Recent SBIR Projects

Year Phase Agency Total Amount
2001 1 NIH $99,772
Project Title: Short-Term Molecular Carcinogenicity Assays
2000 1 NIH $100,000
Project Title: Rodent Disease Diagnostic Laboratory
1992 1 NIH $50,000
Project Title: PIM-1 transgenic mice to detect environmental toxins
1989 1 NIH $50,000
Project Title: An in vitro assay for toxic particulates
1989 2 NIH $550,000
Project Title: Production of murine diagnostic reference reagents

Key People / Management

  Capers McDonald -- President

  Robert E Bird

  James R Ganaway

  John W Harbell

  David Jacobson-Kram

  Bryan Larsen

  Ronald A Lubet

  Robert Peters

  Judith A Poiley

  Danny Ragland

  Ronald Ranieri

  Andrea Rogerd-Back

Company News

There are no news available.